889676-35-1 Usage
Uses
Used in Pharmaceutical Industry:
4-(5-Bromopyridin-3-ylsulphonyl)morpholine 95 is used as an intermediate in the synthesis of new drug candidates for various therapeutic applications. Its ability to form bonds with other molecules allows for the creation of innovative pharmaceutical compounds with specific properties and potential therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical industry, 4-(5-Bromopyridin-3-ylsulphonyl)morpholine 95 serves as a key intermediate in the development of new agrochemical products. Its chemical properties enable the synthesis of compounds with targeted effects on pests or crops, contributing to more efficient and sustainable agricultural practices.
Used in Research and Development:
4-(5-Bromopyridin-3-ylsulphonyl)morpholine 95 is utilized as a building block in research and development for creating new molecules with specific properties. Its versatility in forming bonds with other molecules allows scientists to explore its potential in various applications, including the development of new materials, catalysts, or other specialized compounds.
Overall, 4-(5-Bromopyridin-3-ylsulphonyl)morpholine 95 is a significant chemical compound with a wide range of potential applications across different industries, primarily due to its unique chemical structure and bonding capabilities.
Check Digit Verification of cas no
The CAS Registry Mumber 889676-35-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,9,6,7 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 889676-35:
(8*8)+(7*8)+(6*9)+(5*6)+(4*7)+(3*6)+(2*3)+(1*5)=261
261 % 10 = 1
So 889676-35-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H11BrN2O3S/c10-8-5-9(7-11-6-8)16(13,14)12-1-3-15-4-2-12/h5-7H,1-4H2
889676-35-1Relevant academic research and scientific papers
AZA-HETEROARYL COMPOUNDS AS PI3K-GAMMA INHIBITORS
-
Paragraph 0426; 0430, (2016/09/12)
The present invention provides aza-heteroaryl derivatives of Formula I: and pharmaceutically acceptable salts thereof, wherein X, Y, Z, A, W, R4, R5, and R6 are defined herein, that inhibit the activity of phosphoinositide 3-kinases-gamma (PI3Kγ) and are useful in the treatment of diseases related to the activity of PI3Kγ including, for example, autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
